ONTEX Ontex Group N.V.

Ontex shareholders’ meeting: all resolutions approved by a large majority

Ontex shareholders’ meeting: all resolutions approved by a large majority

Aalst-Erembodegem, Belgium, May 05, 2023 – Ontex Group NV (Euronext Brussels: ONTEX) held its annual shareholders' meeting today, followed by an extraordinary shareholders' meeting. All proposed resolutions were approved by the shareholders by a convincing majority.

Among other things, the shareholders approved a fundamental adjustment to the remuneration policy. This will better align management remuneration with shareholder returns, with a strong emphasis on the share price in three years. The extraordinary shareholders’ meeting also renewed the authorizations for the board of directors within the framework of the authorized capital and for the acquisition of own shares.

Chairman Hans Van Bylen said, "I wish to sincerely thank the shareholders of Ontex for their very clear approval of all the resolutions that the board of directors had proposed to the shareholders’ meeting this year. Several of these resolutions will contribute to the accelerated implementation of our strategic reorientation."

The minutes of the annual and extraordinary shareholders' meetings are available on Ontex's website at:

Contact information

  • Investors         Geoffroy Raskin                  
  • Media              Maarten Verbanck     7      

About Ontex

Ontex is a leading international provider of personal hygiene solutions, with expertise in baby care, feminine care and adult care. Ontex’s innovative products are distributed in around 100 countries through leading retailer brands, lifestyle brands and Ontex brands. Employing some 7,500 people all over the world, Ontex has a presence in 21 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussels and is part of the Bel Mid®. To keep up with the latest news, visit or follow Ontex on , , and .

ONTEX GROUP NV Korte Keppestraat 21 9320 Erembodegem (Aalst) 0550.880.915 RPR Ghent – Division Dendermonde

Attachment



EN
05/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ontex Group N.V.

 PRESS RELEASE

Ontex’s annual shareholders’ meeting: All resolutions approved by a la...

Ontex’s annual shareholders’ meeting: All resolutions approved by a large majority Regulated information Aalst, Belgium, May 5, 2025 – Ontex Group NV, a leading international developer and producer of personal care products, held its annual shareholders’ meeting today. All proposed resolutions were approved by the shareholders with a large majority of votes cast.  The minutes of the annual shareholders’ meeting are available on Ontex’s website at: . Enquiries Investors       Geoffroy Raskin                  Media             Catherine Weyne               About Ontex Ontex is a lea...

 PRESS RELEASE

Jaarlijkse algemene vergadering Ontex: Alle resoluties met grote meerd...

Jaarlijkse algemene vergadering Ontex: Alle resoluties met grote meerderheid goedgekeurd Gereglementeerde informatie Aalst, België, 5 mei 2025 – Ontex Group NV, een toonaangevende internationale ontwikkelaar en producent van persoonlijke verzorgingsproducten, hield vandaag zijn algemene vergadering. Alle voorgestelde resoluties werden door de aandeelhouders goedgekeurd met een grote meerderheid van de uitgebrachte stemmen. De notulen van de jaarlijkse aandeelhoudersvergadering zijn beschikbaar op de website van Ontex: . Inlichtingen Investeerders    Geoffroy Raskin               Media ...

Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi
Carole Braudeau
  • Carole Braudeau

Credit Morning 05/02/2025

The acquisition of IFF Pharma Solutions has been completed|Ontex Q1 25 call notes: Not alarming yet|Biogroup released weak results in 2024|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 02/05/2025

L'acquisition d'IFF Pharma Solutions a été finalisée|Ontex Q1 25 call notes: Not alarming yet|Biogroup : les résultats se contractent en 2024|

ResearchPool Subscriptions

Get the most out of your insights

Get in touch